Sale!

P2RX2 Gene Progressive Hearing Loss Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The P2RX2 gene progressive hearing loss genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the P2RX2 gene, which are linked to progressive hearing loss. This gene plays a crucial role in the function of hair cells within the inner ear, which are essential for normal hearing. Mutations in the P2RX2 gene can lead to deteriorating hearing ability over time, making early detection vital for effective management and treatment options.

The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any genetic anomalies associated with hearing loss. By identifying these mutations early, individuals and their healthcare providers can explore potential interventions, including hearing aids, cochlear implants, or other supportive therapies, to improve quality of life or slow the progression of hearing loss.

Offered at DNA Labs UAE, the cost of the P2RX2 gene progressive hearing loss genetic test is 4400 AED. The test is conducted with precision and confidentiality, ensuring that individuals receive accurate results and the necessary guidance for further steps. For those with a family history of hearing loss or early signs of hearing impairment, this test provides a crucial resource for early detection and intervention, emphasizing the importance of genetic testing in managing hereditary conditions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

P2RX2 Gene Progressive Hearing Loss Genetic Test

Welcome to DNA Labs UAE, your trusted genetic lab for all your testing needs. Today, we will be discussing the P2RX2 gene and its association with progressive hearing loss. We will also delve into the details of our Next-Generation Sequencing (NGS) genetic test for this gene.

Test Name: P2RX2 Gene Progressive Hearing Loss Genetic Test

Components:

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Ear Nose Throat Disorders
  • Doctor: ENT Doctor
  • Test Department: Genetics

Pre Test Information:

Prior to undergoing the P2RX2 gene test, it is essential to provide the clinical history of the patient. This includes information about individuals in the family who have been affected by SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2. A Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with the SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test gene (SLC52A20).

Test Details:

The P2RX2 gene is known to be associated with progressive hearing loss. Our NGS genetic test analyzes the DNA sequence of this gene to detect any mutations or variations that may be causing or contributing to the condition. NGS technology allows for the comprehensive assessment of genetic variations by simultaneously analyzing multiple genes or even the entire genome.

In the case of progressive hearing loss, NGS testing can help identify specific mutations or variations in the P2RX2 gene that may be responsible for the condition. This information is valuable for diagnosis, prognosis, and potential treatment options. It can also aid in genetic counseling and family planning decisions.

It is important to note that genetic testing for progressive hearing loss is typically recommended for individuals with a family history of the condition or those who have experienced early onset hearing loss. Our healthcare professionals and genetic counselors are available to provide further information and guidance on whether NGS testing for the P2RX2 gene is appropriate in your specific case.

At DNA Labs UAE, we strive to provide accurate and reliable genetic testing services. Our P2RX2 Gene Progressive Hearing Loss Genetic Test is designed to assist in the diagnosis and management of progressive hearing loss. Contact us today to schedule an appointment or to learn more about our genetic testing options.

Test Name P2RX2 Gene Progressive hearing loss Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test gene SLC52A20
Test Details

The P2RX2 gene is associated with progressive hearing loss, and a Next-Generation Sequencing (NGS) genetic test can be used to detect mutations or variations in this gene. This type of genetic test analyzes the DNA sequence of the P2RX2 gene to identify any changes that may be causing or contributing to progressive hearing loss.

NGS technology allows for the simultaneous analysis of multiple genes or even the entire genome, providing a comprehensive assessment of genetic variations. In the case of progressive hearing loss, NGS can help identify specific mutations or variations in the P2RX2 gene that may be responsible for the condition.

By identifying the genetic cause of progressive hearing loss, NGS testing can provide valuable information for diagnosis, prognosis, and potential treatment options. It can also help with genetic counseling and family planning decisions.

It’s important to note that genetic testing for progressive hearing loss is typically recommended for individuals with a family history of the condition or those who have experienced an early onset of hearing loss. A healthcare professional or genetic counselor can provide more information and guidance on whether NGS testing for the P2RX2 gene is appropriate in a specific case.